VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Breakthrough! 97.4% Acute Success Rate — Adagio Medical's vCLAS System Charges Toward FDA Approval
Breakthrough! 97.4% Acute Success Rate — Adagio Medical's vCLAS System Charges Toward FDA Approval
May 26, 2026 08:00 CST Updated 11:24
Share:
Adagio Medical
Cardiovascular Disease Treatment Device Developer